• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纠正 NBD1 的能量和结构域界面是恢复 ΔF508 CFTR 折叠和功能所必需的。

Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function.

机构信息

Department of Physiology, McGill University, Montréal, Quebec H3E 1Y6, Canada.

出版信息

Cell. 2012 Jan 20;148(1-2):150-63. doi: 10.1016/j.cell.2011.11.024.

DOI:10.1016/j.cell.2011.11.024
PMID:22265408
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3431169/
Abstract

The folding and misfolding mechanism of multidomain proteins remains poorly understood. Although thermodynamic instability of the first nucleotide-binding domain (NBD1) of ΔF508 CFTR (cystic fibrosis transmembrane conductance regulator) partly accounts for the mutant channel degradation in the endoplasmic reticulum and is considered as a drug target in cystic fibrosis, the link between NBD1 and CFTR misfolding remains unclear. Here, we show that ΔF508 destabilizes NBD1 both thermodynamically and kinetically, but correction of either defect alone is insufficient to restore ΔF508 CFTR biogenesis. Instead, both ΔF508-NBD1 energetic and the NBD1-MSD2 (membrane-spanning domain 2) interface stabilization are required for wild-type-like folding, processing, and transport function, suggesting a synergistic role of NBD1 energetics and topology in CFTR-coupled domain assembly. Identification of distinct structural deficiencies may explain the limited success of ΔF508 CFTR corrector molecules and suggests structure-based combination corrector therapies. These results may serve as a framework for understanding the mechanism of interface mutation in multidomain membrane proteins.

摘要

多结构域蛋白的折叠和错误折叠机制仍知之甚少。尽管 ΔF508 CFTR(囊性纤维化跨膜电导调节因子)的第一个核苷酸结合域(NBD1)的热力学不稳定性部分解释了突变通道在内质网中的降解,并被认为是囊性纤维化的药物靶点,但 NBD1 和 CFTR 错误折叠之间的联系仍不清楚。在这里,我们表明 ΔF508 在热力学和动力学上均使 NBD1 不稳定,但仅纠正其中一个缺陷不足以恢复 ΔF508 CFTR 的生物发生。相反,ΔF508-NBD1 能量和 NBD1-MSD2(跨膜结构域 2)界面稳定性对于类似于野生型的折叠、加工和转运功能都是必需的,这表明 NBD1 能量和拓扑结构在 CFTR 偶联结构域组装中具有协同作用。鉴定出不同的结构缺陷可能解释了 ΔF508 CFTR 校正分子的有限成功,并提示了基于结构的组合校正治疗方法。这些结果可以作为理解多结构域膜蛋白界面突变机制的框架。

相似文献

1
Correction of both NBD1 energetics and domain interface is required to restore ΔF508 CFTR folding and function.纠正 NBD1 的能量和结构域界面是恢复 ΔF508 CFTR 折叠和功能所必需的。
Cell. 2012 Jan 20;148(1-2):150-63. doi: 10.1016/j.cell.2011.11.024.
2
Mechanism-based corrector combination restores ΔF508-CFTR folding and function.基于机制的校正剂组合可恢复 ΔF508-CFTR 的折叠和功能。
Nat Chem Biol. 2013 Jul;9(7):444-54. doi: 10.1038/nchembio.1253. Epub 2013 May 12.
3
Restoration of NBD1 thermal stability is necessary and sufficient to correct ∆F508 CFTR folding and assembly.恢复NBD1的热稳定性对于纠正∆F508 CFTR折叠和组装是必要且充分的。
J Mol Biol. 2015 Jan 16;427(1):106-20. doi: 10.1016/j.jmb.2014.07.026. Epub 2014 Jul 30.
4
Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure.人类囊性纤维化跨膜传导调节因子第一个核苷酸结合结构域中ΔF508突变对结构域折叠和结构的影响。
J Biol Chem. 2005 Jan 14;280(2):1346-53. doi: 10.1074/jbc.M410968200. Epub 2004 Nov 3.
5
The DeltaF508 cystic fibrosis mutation impairs domain-domain interactions and arrests post-translational folding of CFTR.ΔF508 囊性纤维化突变会损害结构域间的相互作用,并阻止囊性纤维化跨膜传导调节因子(CFTR)的翻译后折叠。
Nat Struct Mol Biol. 2005 Jan;12(1):17-25. doi: 10.1038/nsmb882. Epub 2004 Dec 26.
6
Requirements for efficient correction of ΔF508 CFTR revealed by analyses of evolved sequences.通过对进化序列的分析揭示了 ΔF508 CFTR 有效校正的要求。
Cell. 2012 Jan 20;148(1-2):164-74. doi: 10.1016/j.cell.2011.11.023.
7
Diminished self-chaperoning activity of the DeltaF508 mutant of CFTR results in protein misfolding.囊性纤维化跨膜传导调节因子(CFTR)的ΔF508突变体自我陪伴活性降低,导致蛋白质错误折叠。
PLoS Comput Biol. 2008 Feb 29;4(2):e1000008. doi: 10.1371/journal.pcbi.1000008.
8
The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain.ΔF508 CFTR 的主要折叠缺陷和挽救出现在突变结构域翻译期间。
PLoS One. 2010 Nov 30;5(11):e15458. doi: 10.1371/journal.pone.0015458.
9
The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis.囊性纤维化致病突变 deltaF508 影响囊性纤维化跨膜电导调节因子生物发生的多个步骤。
J Biol Chem. 2010 Nov 12;285(46):35825-35. doi: 10.1074/jbc.M110.131623. Epub 2010 Jul 28.
10
ΔF508-CFTR Modulator Screen Based on Cell Surface Targeting of a Chimeric Nucleotide Binding Domain 1 Reporter.ΔF508-CFTR 调节剂基于嵌合核苷酸结合域 1 报告基因细胞表面靶向的筛选。
SLAS Discov. 2018 Sep;23(8):823-831. doi: 10.1177/2472555218763310. Epub 2018 Mar 13.

引用本文的文献

1
Thermodynamic Coupling between Folding Correctors and the First of Dimerized Nucleotide Binding Domains in CFTR.囊性纤维化跨膜传导调节因子中折叠校正因子与二聚化核苷酸结合结构域首个结构域之间的热力学偶联
ACS Bio Med Chem Au. 2025 Jul 30;5(4):593-601. doi: 10.1021/acsbiomedchemau.5c00014. eCollection 2025 Aug 20.
2
Thermodynamic basis for CFTR activity potentiation.囊性纤维化跨膜传导调节因子(CFTR)活性增强的热力学基础。
Res Sq. 2025 Aug 12:rs.3.rs-7339733. doi: 10.21203/rs.3.rs-7339733/v1.
3
Thermodynamic coupling between folding correctors and the first of dimerized nucleotide binding domains in CFTR.

本文引用的文献

1
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809.通过研究药物 VX-809 纠正体外 F508del-CFTR 蛋白加工缺陷。
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18843-8. doi: 10.1073/pnas.1105787108. Epub 2011 Oct 5.
2
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.一项研究 VX-809(一种研究用的 CFTR 校正化合物)的 IIa 期临床研究结果,该化合物用于 F508del-CFTR 突变纯合子的囊性纤维化患者。
Thorax. 2012 Jan;67(1):12-8. doi: 10.1136/thoraxjnl-2011-200393. Epub 2011 Aug 8.
3
囊性纤维化跨膜传导调节因子(CFTR)中折叠校正因子与二聚化核苷酸结合结构域首个结构域之间的热力学偶联。
Res Sq. 2025 Jun 17:rs.3.rs-6890276. doi: 10.21203/rs.3.rs-6890276/v1.
4
How Effectively Can Oxidative Stress and Inflammation Be Reversed When CFTR Function Is Pharmacologically Improved?当CFTR功能通过药物得到改善时,氧化应激和炎症能在多大程度上得到有效逆转?
Antioxidants (Basel). 2025 Mar 4;14(3):310. doi: 10.3390/antiox14030310.
5
Target Identification with Live-Cell Photoaffinity Labeling and Mechanism of Action Elucidation of ARN23765, a Highly Potent CFTR Corrector.通过活细胞光亲和标记进行靶点鉴定以及强效CFTR校正剂ARN23765的作用机制阐释
J Med Chem. 2025 Feb 27;68(4):4596-4618. doi: 10.1021/acs.jmedchem.4c02654. Epub 2025 Feb 10.
6
Functional rescue of F508del-CFTR through revertant mutations introduced by CRISPR base editing.通过CRISPR碱基编辑引入的回复突变实现F508del-CFTR的功能挽救。
Mol Ther. 2025 Mar 5;33(3):970-985. doi: 10.1016/j.ymthe.2025.01.011. Epub 2025 Jan 10.
7
ATP-dependent thermoring basis for the heat unfolding of the first nucleotide-binding domain isolated from human CFTR.从人囊性纤维化跨膜传导调节因子中分离出的第一个核苷酸结合结构域热展开的ATP依赖热环基础。
Res Sq. 2024 Nov 21:rs.3.rs-5479740. doi: 10.21203/rs.3.rs-5479740/v1.
8
Proteostasis Landscapes of Cystic Fibrosis Variants Reveals Drug Response Vulnerability.囊性纤维化变体的蛋白质稳态格局揭示药物反应易损性。
bioRxiv. 2025 Jan 17:2024.07.10.602964. doi: 10.1101/2024.07.10.602964.
9
Potentiation of BKCa channels by cystic fibrosis transmembrane conductance regulator correctors VX-445 and VX-121.囊性纤维化跨膜电导调节因子校正剂 VX-445 和 VX-121 对 BKCa 通道的增强作用。
J Clin Invest. 2024 Jul 2;134(16):e176328. doi: 10.1172/JCI176328.
10
HERC3 facilitates ERAD of select membrane proteins by recognizing membrane-spanning domains.HERC3 通过识别跨膜结构域促进特定膜蛋白的 ERAD。
J Cell Biol. 2024 Jul 1;223(7). doi: 10.1083/jcb.202308003. Epub 2024 May 9.
Ligand-driven vectorial folding of ribosome-bound human CFTR NBD1.
配体驱动的核糖体结合人 CFTR NBD1 的定向折叠。
Mol Cell. 2011 Mar 18;41(6):682-92. doi: 10.1016/j.molcel.2011.02.027.
4
Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR.一种纠正F508del-CFTR转运缺陷的NBD1结合药理学伴侣分子的鉴定。
Chem Biol. 2011 Feb 25;18(2):231-42. doi: 10.1016/j.chembiol.2010.11.016.
5
The primary folding defect and rescue of ΔF508 CFTR emerge during translation of the mutant domain.ΔF508 CFTR 的主要折叠缺陷和挽救出现在突变结构域翻译期间。
PLoS One. 2010 Nov 30;5(11):e15458. doi: 10.1371/journal.pone.0015458.
6
Small molecule correctors of F508del-CFTR discovered by structure-based virtual screening.基于结构的虚拟筛选发现 F508del-CFTR 的小分子校正剂。
J Comput Aided Mol Des. 2010 Dec;24(12):971-91. doi: 10.1007/s10822-010-9390-0. Epub 2010 Oct 26.
7
Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle.真核 CLC 转运蛋白的结构确定了转运循环中的中间状态。
Science. 2010 Oct 29;330(6004):635-41. doi: 10.1126/science.1195230. Epub 2010 Sep 30.
8
Integrated biophysical studies implicate partial unfolding of NBD1 of CFTR in the molecular pathogenesis of F508del cystic fibrosis.综合生物物理研究表明,CFTR 的 NBD1 部分展开与 F508del 囊性纤维化的分子发病机制有关。
Protein Sci. 2010 Oct;19(10):1932-47. doi: 10.1002/pro.480.
9
Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide-binding domain 1.热变性研究表明,CFTR 中的致病 F508del 突变在热力学上使核苷酸结合域 1 不稳定。
Protein Sci. 2010 Oct;19(10):1917-31. doi: 10.1002/pro.479.
10
The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis.囊性纤维化致病突变 deltaF508 影响囊性纤维化跨膜电导调节因子生物发生的多个步骤。
J Biol Chem. 2010 Nov 12;285(46):35825-35. doi: 10.1074/jbc.M110.131623. Epub 2010 Jul 28.